Bayesian Capital Management’s Gevo GEVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-23,200
Closed -$45.5K 289
2025
Q3
$45.5K Buy
+23,200
New +$37.8K 0.01% 503
2024
Q4
Sell
-10,400
Closed -$17K 798
2024
Q3
$17K Buy
+10,400
New +$8.43K ﹤0.01% 641
2024
Q2
Sell
-35,352
Closed -$27.2K 881
2024
Q1
$27.2K Buy
+35,352
New +$30.7K ﹤0.01% 744
2022
Q1
Sell
-18,500
Closed -$79K 819
2021
Q4
$79K Buy
+18,500
New +$113K 0.03% 345
2021
Q1
Sell
-18,994
Closed -$81K 593
2020
Q4
$81K Buy
+18,994
New +$31.7K 0.02% 419

Other funds holding GEVO

Bayesian Capital Management's GEVO Position: Q4 2025 in Review

Bayesian Capital Management sold out of Gevo (GEVO) in Q4 2025, closing a stake of 23,200 shares — an estimated $45.5K sold.

Bayesian Capital Management first reported a position in GEVO in Q4 2020 and held it in 5 quarters. The position peaked at $81K in Q4 2020. 155 funds tracked by Wall St. Rank hold GEVO as of Q4 2025.

  • Bayesian Capital Management reported no remaining Gevo position as of Q4 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 23,200 Gevo shares in Q4 2025, an estimated $45.5K.
  • Bayesian Capital Management first reported a position in Gevo in Q4 2020 and held it in 5 quarters.
  • Bayesian Capital Management's Gevo position peaked at $81K in Q4 2020.
  • 155 funds tracked by Wall St. Rank held Gevo as of Q4 2025.

Based on Bayesian Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.